aTYR PHARMA INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
aTYR PHARMA INC (ATYR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 14.01 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 13.88M shares, a 46.76% increase year-over-year.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 9.45M shares, a 64.13% increase year-over-year.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 5.76M shares, a 45.05% increase year-over-year.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 3.97M shares, a 115.83% increase year-over-year.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 9.66M shares, a 55.62% increase from fiscal 2024.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.21M shares, a 52.55% increase from fiscal 2023.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.07M shares, a 30.13% increase from fiscal 2022.
- aTYR PHARMA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.13M shares, a 117.71% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 14.01M shares 10-Q · filed 2026-08-07 | |||||||
| 2026-03-31 | 13.88M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 9.66M shares 10-K · filed 2026-03-05 | |||||||
| 2025-09-30 | 9.86M shares 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | 9.78M shares 10-Q · filed 2026-08-07 | |||||||
| 2025-03-31 | 9.45M shares 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | 6.21M shares 10-K · filed 2026-03-05 | |||||||
| 2024-09-30 | 6.11M shares 10-Q · filed 2025-11-06 | |||||||
| 2024-06-30 | 5.89M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 5.76M shares 10-Q · filed 2025-05-07 | |||||||
| 2023-12-31 | 4.07M shares 10-K · filed 2026-03-05 | |||||||
| 2023-09-30 | 4.08M shares 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | 4.08M shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 3.97M shares 10-Q · filed 2024-05-02 | |||||||
| 2022-12-31 | 3.13M shares 10-K · filed 2025-03-13 | |||||||
| 2022-09-30 | 3.11M shares 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | 3.08M shares 10-Q · filed 2023-08-09 | |||||||
| 2022-03-31 | 1.84M shares 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | 1.44M shares 10-K · filed 2024-03-14 | |||||||
| 2021-09-30 | 1.29M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 1.31M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 913.67K shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 599.72K shares 10-K · filed 2023-03-14 | |||||||
| 2020-09-30 | 598.27K shares 10-Q · filed 2020-11-13 | 598.27K shares 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | 709.35K shares 10-Q · filed 2020-08-13 | 709.35K shares 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | 502.00K shares 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | 966.86K shares 10-K · filed 2022-03-15 | |||||||
| 2019-09-30 | 1.47M shares 10-Q · filed 2020-11-13 | 1.47M shares 10-Q · filed 2020-11-13 | ||||||
| 2019-06-30 | 1.48M shares 10-Q · filed 2020-08-13 | 1.48M shares 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | 1.47M shares 10-Q · filed 2020-05-12 | 20.60M shares 10-Q · filed 2019-05-14 | ||||||
| 2018-12-31 | 1.67M shares 10-K · filed 2021-03-24 | 23.34M shares 10-K · filed 2019-03-26 | ||||||
| 2018-09-30 | 1.70M shares 10-Q · filed 2019-11-14 | 23.76M shares 10-Q · filed 2018-11-14 | 1.70M shares 10-Q · filed 2019-11-14 | 23.76M shares 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | 1.72M shares 10-Q · filed 2019-08-14 | 24.10M shares 10-Q · filed 2018-08-14 | 1.72M shares 10-Q · filed 2019-08-14 | 24.10M shares 10-Q · filed 2018-08-14 | ||||
| 2018-03-31 | 23.76M shares 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | 1.63M shares 10-K · filed 2020-03-26 | 22.81M shares 10-K · filed 2018-03-20 | ||||||
| 2017-09-30 | 22.86M shares 10-Q · filed 2018-11-14 | 22.86M shares 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | 5.03M shares 10-Q · filed 2018-08-14 | 5.03M shares 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | 4.88M shares 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | 4.25M shares 10-K · filed 2019-03-26 | |||||||
| 2016-09-30 | 4.42M shares 10-Q · filed 2017-11-14 | 4.42M shares 10-Q · filed 2016-11-14 | 4.42M shares 10-Q · filed 2017-11-14 | 4.42M shares 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | 4.01M shares 10-Q · filed 2017-08-14 | 4.01M shares 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | 3.79M shares 10-Q · filed 2017-05-11 | |||||||
| 2015-12-31 | 2.67M shares 10-K · filed 2018-03-20 | |||||||
| 2015-09-30 | 1.51M shares 10-Q · filed 2016-11-14 | 1.51M shares 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | 1.19M shares 10-Q · filed 2016-08-10 | 1.19M shares 10-Q · filed 2016-08-10 | ||||||
| 2015-03-31 | 19.73M shares 10-Q · filed 2016-05-11 | |||||||
| 2014-12-31 | 10.87M shares 10-K · filed 2017-03-16 | |||||||
| 2014-09-30 | 10.70M shares 10-Q · filed 2015-11-10 | 10.70M shares 10-Q · filed 2015-11-10 | ||||||
| 2014-06-30 | 10.44M shares 10-Q · filed 2015-08-12 | 10.44M shares 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | 10.48M shares 10-Q · filed 2015-06-18 | |||||||
| 2013-12-31 | 10.17M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |